The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Second cancer incidence in CLL patients receiving BTK inhibitors.
 
David Alan Bond
No Relationships to Disclose
 
Ying Huang
No Relationships to Disclose
 
James L Fisher
No Relationships to Disclose
 
Amy S. Ruppert
No Relationships to Disclose
 
Dwight Hall Owen
Consulting or Advisory Role - AstraZeneca; L&M Policy Research
Research Funding - Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Merck Sharp & Dohme (Inst); Palobiofarma (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Erin Marie Bertino
Consulting or Advisory Role - Boehringer Ingelheim; Takeda
 
Kerry Anne Rogers
Consulting or Advisory Role - Acerta Pharma
Research Funding - Abbvie; Genentech
 
Seema Ali Bhat
Speakers' Bureau - Janssen/Pharmacyclics
 
Samantha Mary Jaglowski
Consulting or Advisory Role - Juno Therapeutics; Kite, a Gilead company; Novartis
Speakers' Bureau - E-Squared Communications
Patents, Royalties, Other Intellectual Property - Pharmacyclics
Travel, Accommodations, Expenses - Kite, a Gilead company
 
Michael R. Grever
Consulting or Advisory Role - Pharmacyclics
Research Funding - AstraZeneca
 
John C. Byrd
Consulting or Advisory Role - Acerta Pharma; Genentech; Jazz Pharmaceuticals; Pharmacyclics
Research Funding - Acerta Pharma (Inst); Genentech (Inst); Janssen (Inst); Pharmacyclics (Inst)
 
Kami J. Maddocks
Honoraria - Bayer; Novartis; Pharmacyclics; Teva
Research Funding - Bristol-Myers Squibb; Merck; Pharmacyclics
 
Jennifer Ann Woyach
Consulting or Advisory Role - Janssen; Pharmacyclics
Research Funding - Abbvie; Janssen; Karyopharm Therapeutics; Loxo; MorphoSys; Pharmacyclics